Drugs / Polyethylene Glycol (PEG 3350)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01885104 | Apr → Sep 2013 | constipation disorder | Bayer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyethylene Glycol (PEG 3350) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01885104 ↗ |
| Route | Oral | “Oral 17 g dose of PEG 3350 solution concentrate” NCT01885104 ↗ |